Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
52.00    -3.50 (-6.31%)
Bid:
51.00
Ask:
53.00
Spread: 2.00 (3.922%)
Market Cap: £99.77m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Completion of Debt Restructuring

1 Apr 2019 07:00

RNS Number : 5819U
Iofina PLC
01 April 2019
 

 

1 April 2019

Iofina plc

("Iofina", the "Group", or the "Company")

(LSE AIM: IOF)

 

 

Completion of Debt Restructuring

 

Extension of Term and Removal of Debt Convertibility

 

Iofina, specialists in the exploration and production of iodine and halogen-based specialty chemical derivatives, is pleased to announce it has now finalised the debt restructure documentation with the terms detailed in the Company's announcement on 12 February 2019.

 

Commenting, President and CEO Dr. Tom Becker stated: ''The Board is delighted to announce the completion of the debt restructuring documentation. This debt extension enables us to continue with our growth strategy, as we seek to take full advantage of the positive conditions in the global iodine market, and build our position as one of the industry's best operators."

 

 

The new terms are as follows:

 

Notes:

· Extension of repayment term to 1 July 2020

· Removal of debt convertibility with Notes switching to a term loan

· Interest rate adjusted to 7.5% beginning 1 January 2019

· Interest paid to Noteholders quarterly in arrears from beginning of 2019

 

Facility:

· Extension of repayment term to 1 July 2020

· Interest rate adjusted to 7.5% beginning 1 January 2019, rising to 12% on 1 June 2019

· Interest paid to Stena quarterly in arrears from beginning of 2019

 

Debt as at 31 December 2018 was comprised approximately of:

· $22.37m under Notes

· $3.26m under Facility

 

Other existing provisions relating to the Notes and the Facility continue in effect. In particular, all debt may be repaid in whole or in part at any time without penalty, the Facility is to be repaid in priority to the Notes, and the entirety of the debt is secured against the assets of the Group.

 

Enquiries:

 

Dr. Tom Becker, CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Christopher Raggett/Giles Rolls/Anthony Adams (corporate finance)

Camille Gochez (ECM)

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Media Contact:

Charles Goodwin/Harriet Jackson

Yellow Jersey PR Limited

Tel: +44 (0)7544 275 882

About Iofina:

Iofina specialises in the exploration and production of iodine, halogen based specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America, based on Iofina's WET® IOsorb® technology. Iofina has production operations in the United States, specifically in Kentucky and Oklahoma. It is a vertically integrated company, covering the process from the production of iodine in the field, to the manufacture of the chemical end-products derived from iodine, supplying them to the consumer, and the recycling of iodine using iodinated side-streams from waste chemical processes. Iofina utilises its portfolio of patented and patent-pending technology, and proprietary methods and trademarks throughout all business lines.

www.iofina.com

 

THE INFORMATION COMMUNICATED IN THIS ANNOUNCEMENT IS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCCKDDQKBKBNNN
Date   Source Headline
22nd Dec 20147:00 amRNSMarket update
16th Dec 20147:00 amRNSBoard Change
8th Dec 20147:00 amRNSExercise of Options and Total Voting Rights
28th Nov 20144:35 pmRNSPrice Monitoring Extension
17th Nov 20147:00 amRNSIssue of Patent and Market Update
30th Oct 20147:00 amRNSExercise of Options and Total Voting Rights
15th Oct 20147:00 amRNSTotal Voting Rights
10th Oct 20142:56 pmRNSTR-1: Notification of Major Interest in Shares
8th Oct 20149:15 amRNSTR-1: Notification of Major Interest in Shares
6th Oct 20147:00 amRNSProduction & Water Permit Update
30th Sep 20147:00 amRNSInterim Results
18th Sep 20147:00 amRNSProduction Update
5th Sep 20147:00 amRNSAppointment of CEO
14th Aug 20147:00 amRNSJuly Production Update
9th Jul 20147:00 amRNSJune Production Update
18th Jun 20147:00 amRNSExercise of Options and Total Voting Rights
10th Jun 20143:42 pmRNSResult of AGM & Appointment of Directors
3rd Jun 20147:00 amRNSIodine Production Update
16th May 20141:58 pmRNSNotice of AGM
6th May 20147:01 amRNSApril Iodine Production Update
29th Apr 20147:00 amRNSSuccessful Completion of Convertible Bond
28th Apr 20147:00 amRNSBoard Changes
25th Apr 20147:00 amRNSFinal Results
23rd Apr 20147:00 amRNSProduction Update
22nd Apr 20147:01 amRNSWater Project Update
15th Apr 20144:40 pmRNSAppointment of Director (amended)
14th Apr 20147:00 amRNSProduction Update
10th Apr 20148:03 amRNSAppointment of Director
7th Apr 20147:00 amRNSHolding(s) in Company
2nd Apr 20144:39 pmRNSHolding(s) in Company
27th Mar 20147:00 amRNSMarket update
20th Mar 20147:00 amRNSResignation and appointment of Director
7th Mar 20147:00 amRNSAmendment to the terms of Convertible Bond
28th Feb 20147:01 amRNSIO#4 and IO#5 Update
3rd Feb 20147:00 amRNSNon-Core Water Project Update
29th Jan 20147:00 amRNSOperational Update
28th Jan 20147:00 amRNSHolding(s) in Company
13th Jan 20147:00 amRNSChange of Adviser
6th Jan 201410:12 amRNSDirector Transfer of Shares
23rd Dec 20137:00 amRNSWater Project Update
17th Dec 20133:35 pmRNSDirector Dealing
17th Dec 201310:27 amRNSDirector Dealing
17th Dec 20137:00 amRNS2013 Review and 2014 Outlook
13th Dec 20132:55 pmRNSWater Permit
29th Nov 20137:00 amRNSDirectors' Disclosure
22nd Nov 20137:00 amRNSBoard Change
20th Nov 20137:00 amRNSOperational Update
12th Nov 20137:01 amRNSGrant of Options to Directors
5th Nov 20131:45 pmRNSChange of Registered Office
31st Oct 20137:00 amRNSCommissioning of IO#3 iodine extraction plant

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.